SCHEMBL25515155

SCHEMBL25515155

C[C@H](N)C(=O)c1cc2ccccn2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.43
IMPDH2 P12268 1/20 0.37
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 2/20 0.36
POLB P06746 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.36
SSTR4 P31391 1/20 0.36
ALOX15 P16050 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
METTL3 Q86U44 1/20 0.32
METTL14 Q9HCE5 1/20 0.32
PTGS1 P23219 2/20 0.32
PTGS2 P35354 2/20 0.32
ELANE P08246 1/20 0.32
SUV39H2 Q9H5I1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25512171 1.00 CHRNA7 (0.43) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL25515150 1.00 CHRNA7 (0.43) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL14669997 0.87 CHRNA7 (0.45) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL25515287 0.86 CHRNA7 (0.44) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL25509367 0.83 CHRNA7 (0.45) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL25509366 0.83 CHRNA7 (0.45) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL25509368 0.83 CHRNA7 (0.45) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL25516553 0.79 CHRNA7 (0.42) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL12647211 0.78 CHRNA7 (0.48) CHRNA7IMPDH2MAPTALDH1A1NPC1
SCHEMBL1421391 0.78 CHRNA7 (0.48) CHRNA7IMPDH2MAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081306-A1 INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT TACTOGEN INC (US) 2023-05-11 WO disclosed